Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (221-230 of 415) with videos related to

Pageof 42
Sort By:
European Journal of Preventive Cardiology|December 11, 2021
Cardiovascular risk assessment in people living with HIV compared to the general populationBenoît Delabays, Matthias Cavassini, Jose Damas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2017
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination ScheduleOlivia Veit, Cristina Domingo, Matthias Niedrig, et al.
The Lancet. Infectious Diseases|February 26, 2013
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trialMaryline Bonnet, Nilesh Bhatt, Elisabeth Baudin, et al.
AIDS (London, England)|April 7, 2007
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudineChristian Laurent, Charles Kouanfack, Sinata Koulla-Shiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2022
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV CoinfectionEveline Hofmann, Bernard Surial, Noémie Boillat-Blanco, et al.
HIV Medicine|February 23, 2022
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
HIV Medicine|February 25, 2025
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfectionCharles Béguelin, Bernard Surial, Eveline Hofmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2023
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort StudyLukas Baumann, Dominique L Braun, Matthias Cavassini, et al.
Annals of Internal Medicine|March 15, 2021
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort StudyBernard Surial, Catrina Mugglin, Alexandra Calmy, et al.
AIDS (London, England)|January 18, 2023
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort studyFanny Blondet, Vanessa Kraege, Matthias Cavassini, et al.
Pageof 42

Showing results (221-230 of 415) with videos related to

Sort By:
Pageof 42
European Journal of Preventive Cardiology|December 11, 2021
Cardiovascular risk assessment in people living with HIV compared to the general populationBenoît Delabays, Matthias Cavassini, Jose Damas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2017
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination ScheduleOlivia Veit, Cristina Domingo, Matthias Niedrig, et al.
The Lancet. Infectious Diseases|February 26, 2013
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trialMaryline Bonnet, Nilesh Bhatt, Elisabeth Baudin, et al.
AIDS (London, England)|April 7, 2007
Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudineChristian Laurent, Charles Kouanfack, Sinata Koulla-Shiro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2022
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV CoinfectionEveline Hofmann, Bernard Surial, Noémie Boillat-Blanco, et al.
HIV Medicine|February 23, 2022
Women with HIV transitioning through menopause: Insights from the Swiss HIV Cohort Study (SHCS)Anna Hachfeld, Andrew Atkinson, Petra Stute, et al.
HIV Medicine|February 25, 2025
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfectionCharles Béguelin, Bernard Surial, Eveline Hofmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2023
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort StudyLukas Baumann, Dominique L Braun, Matthias Cavassini, et al.
Annals of Internal Medicine|March 15, 2021
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort StudyBernard Surial, Catrina Mugglin, Alexandra Calmy, et al.
AIDS (London, England)|January 18, 2023
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort studyFanny Blondet, Vanessa Kraege, Matthias Cavassini, et al.
Pageof 42